European protocols for the diagnosis and initial treatment of interstitial lung disease in children

Thorax

Volumn 70, Issue 11, 2015, Pages 1078-1084

  Bush, Andrew ^a   Cunningham, Steve ^b   De Blic, Jacques ^c,d   Barbato, Angelo ^e   Clement, Annick ^f   Epaud, Ralph ^g   Hengst, Meike ^h   Kiper, Nural ⁱ   Nicholson, Andrew G ^a   Wetzke, Martin ^j   Snijders, Deborah ^e   Schwerk, Nicolaus ^j   Griese, Matthias ^h  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF PADOVA   (Italy)

^f ARMAND TROUSSEAU HOSPITAL   (France)

^g FACULTÉ DE MÉDECINE   (France)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ HACETTEPE UNIVERSITY   (Turkey)

^j HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISOLONE;

BLOOD ANALYSIS; BRONCHOSCOPY; CHILD; CHILDHOOD DISEASE; CLINICAL PROTOCOL; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; EXERCISE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC SCREENING; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; INTERSTITIAL LUNG DISEASE IN CHILDREN; LUNG BIOPSY; LUNG LAVAGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; EUROPE; LUNG DISEASES, INTERSTITIAL; MORBIDITY; PROCEDURES;

BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; CHILD; CLINICAL PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; EUROPE; HUMANS; LUNG DISEASES, INTERSTITIAL; MORBIDITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84943637569     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207349     Document Type: Review

References (35)

1. Coultas DB, Zumwalt RE, Black WC, et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150:967-72.
2. Hime NJ, Zurynski Y, Fitzgerald D, et al. Childhood interstitial lung disease: a systematic review. Pediatr Pulmonol. Published Online First: 30 Apr 2015. doi:10.1002/ppul.23183
3. Clement A, Allen J, Corrin B, et al. Task Force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004;24:686-97.
4. Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007;176:1120-8.
5. Deterding R, Young L, Dishop M, et al. Diffuse lung disease in older children: report of the ChILD network review[Abstract]. Am J Respir Crit Care Med 2007;175:A148.
6. Rice A, Tran-Dang MA, Bush A, et al. Diffuse lung disease in infancy and childhood: expanding the chILD classification. Histopathology 2013;63:743-55.
7. Bush A, Anthony G, Barbato A, et al. Research in progress: put the orphanage out of business. Thorax 2013;68:971-3.
8. Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013;188:376-94.
9. Andersen C, Ramsay JA, Nogee LM, et al. Recurrent familial neonatal deaths: hereditary surfactant protein B deficiency. Am J Perinatol 2000;17:219-24.
10. Wambach JA, Casey AM, Fishman MP, et al. Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am J Respir Crit Care Med 2014;189:1538-43.
11. Melly L, Sebire NJ, Malone M, et al. Capillary apposition and density in the diagnosis of alveolar capillary dysplasia. Histopathology 2008;53:450-7.
12. Thouvenin G, Abou Taam R, Flamein F, et al. Characteristics of disorders associated with genetic mutations of surfactant protein C. Arch Dis Child 2010;95:449-54.
13. Glasser SW, Witt TL, Senft AP, et al. Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2009;297:L64-72.
14. Glasser SW, Senft AP, Maxfield MD, et al. Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury. Respir Res 2013;14:19.
15. Doan ML, Guillerman RP, Dishop MK, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008;63:366-73.
16. Hong S-B, Kim HJ, Huh JW, et al. A cluster of lung injury associated with home humidifier use: clinical, radiological and pathological description of a new syndrome. Thorax 2014;69:694-702.
17. Kim HJ, Lee M-S, Hong S-B, et al. A cluster of lung injury cases associated with home humidifier use: an epidemiological investigation. Thorax 2014;69:703-8.
18. Kim KW, Ahn K, Yang HJ, et al. Humidifier disinfectant-associated children's interstitial lung disease. Am J Respir Crit Care Med 2014;189:48-56.
19. Bush A, Sheppard M, Warner JO. Chloroquine in idiopathic pulmonary haemosiderosis. Arch Dis Child 1992;67:625-7.
20. Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol 2004;38:369-78.
21. Kerby GS, Wagner BD, Popler J, et al. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol 2013;48:1008-15.
22. Greening AP, Hughes JM. Serial estimations of carbon monoxide diffusing capacity in intrapulmonary haemorrhage. Clin Sci (Lond) 1981;60:507-12.
23. Sondheimer HM, Lung MC, Brugman SM, et al. Pulmonary vascular disorders masquerading as interstitial lung disease. Pediatr Pulmonol 1995;20:284-8.
24. Has C, Spartà G, Kiritsi D, et al. Integrin α3 mutations with kidney, lung, and skin disease. N Engl J Med 2012;366:1508-14.
25. Nicolaou N, Margadant C, Kevelam SH, et al. Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J Clin Invest 2012;122:4375-87.
26. Copley SJ, Coren M, Nicholson AG, et al. Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR Am J Roentgenol 2000;174:549-54.
27. Brody AS, Guillerman RP. Don't let radiation scare trump patient care: 10 ways you can harm your patients by fear of radiation-induced cancer from diagnostic imaging. Thorax 2014;69:782-4.
28. Long FR, Castile RG. Technique and clinical applications of full-inflation and end-exhalation controlled-ventilation chestCT in infants and young children. Pediatr Radiol 2001;31:413-22.
29. de Blic J, Midulla F, Barbato A, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000;15:217-31.
30. Chadelat K, Baculard A, Grimfeld A, et al. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr Pulmonol 1993;16:41-7.
31. Günay E, Firat Güven S, et al. Pulmonary involvement in sea-blue histiocytosis. Tuberk Toraks 2012;60:176-9.
32. Wallis C, Whitehead B, Malone M, et al. Pulmonary alveolar microlithiasis in childhood: diagnosis by transbronchial biopsy. Pediatr Pulmonol 1996;21:62-4.
33. Goyal A, Gupta D, Agarwal R, et al. Value of different bronchoscopic sampling techniques in diagnosis of sarcoidosis: a prospective study of 151 patients. J Bronchology Interv Pulmonol 2014;21:220-6.
34. Young LR, Brody AS, Inge TH, et al. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest 2011;139:1060-71.
35. Langston C, Patterson K, Dishop MK, et al, chILD Pathology Co-operative Group A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group. Pediatr Dev Pathol 2006;9:173-80.